Release Date: 10/04/12 08:58 Summary: Final share buy-back notice - Appendix 3F Price Sensitive: No Download Document 61.08KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling